Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System
Clinical trial NCT05293639 · COMPLETED
Trial details
- NCT number
- NCT05293639
- Sponsor
- Biosense Webster, Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-18
- Primary completion
- 2023-12-11
- Enrollment
- 362
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.